Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins.

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• B cell chronic lymphocytic leukemia (CLL) involves B lymphocyte accumulation due to proliferation and resistance to apoptosis.
• B cell receptor signaling is crucial in CLL, presenting opportunities for targeted therapies.

Purpose of the Study:

• To investigate signaling protein expression in CLL using high-throughput RPPA.
• To identify potential therapeutic targets by comparing protein profiles in CLL patients and healthy controls.

Main Methods:

• Analyzed B lymphocytes from 57 CLL patients and 11 healthy subjects using reverse phase protein array (RPPA).
• Validated RPPA findings using Western blotting and confocal microscopy.
• Assessed activation/expression of key signaling proteins across different pathways.

Main Results:

• Identified significant differences in apoptosis-related molecules (HSP70, Smac/DIABLO, cleaved PARP, cleaved caspase-6) between CLL patients and controls.
• Observed trends in other proteins including HS1, γ-tubulin, and signaling kinases (PKC, p38 MAPK, NF-κB, Bcl2, Src).
• Found differential expression of ZAP70, PKC-ζλ, and CD45 in relation to IGHV mutation status.

Conclusions:

• RPPA is effective for simultaneous analysis of multiple signaling molecules in CLL.
• Several identified molecules, particularly those regulating apoptosis, warrant further investigation as potential therapeutic targets for CLL.